文献速递颈动脉与弓上血管

颈动脉内膜剥脱术与双层微网颈动脉支架置入术比较:单中心回顾性研究的当代结果

Carotid Endarterectomy versus Carotid Artery Stenting With Double-Layer Micromesh Carotid Stent: Contemporary Results of a Single-Center Retrospective Study.
PubMed 文献 · Ann Vasc Surg · 2021-12-11

该单中心回顾性研究分析了119例严重颈动脉狭窄患者,86例行颈动脉内膜剥脱术(CEA),33例行颈动脉支架置入术(CAS)并使用Roadsaver®双层微网支架。随访平均22.3±3.4个月(最短6个月,最长36个月),CEA组死亡概率低于CAS组(P=0.036),再狭窄和心血管事件概率两组无差异。作者认为CEA仍是严重颈动脉狭窄的金标准,但CAS在部分临床情况下可考虑为有用且安全的替代选择。

要点

  • CEA组死亡概率低于CAS组(P=0.036),再狭窄和心血管事件两组无差异。
  • 随访期间共观察到4例死亡、2例心血管事件和12例再狭窄。
  • 作者认为CEA仍是严重颈动脉狭窄的金标准,CAS在部分临床情况下可考虑为有用且安全的替代选择。

核心结论

  • 尽管CEA仍是严重颈动脉狭窄治疗的金标准,但使用新型双层微网支架的CAS在部分临床情况下可考虑为有用且安全的替代选择。

研究设计与样本

  • 单中心回顾性分析纳入119例接受颈动脉狭窄治疗的患者,分为CEA组(86例)和CAS组(33例),所有狭窄均经影像学检查评估。
  • 主要终点为总体死亡和心血管原因相关死亡、无卒中生存及再狭窄,随访最短6个月、最长36个月(平均22.3±3.4个月),所有患者均接受双功超声复查。

主要发现

  • 全队列119例中86例行CEA、33例行CAS,两组危险因素分布相当。
  • 随访期间共观察到4例死亡、2例心血管事件和12例再狭窄。
  • CEA组死亡概率低于CAS组(P=0.036),再狭窄和心血管事件概率在CAS组与CEA组之间无差异。

临床怎么用

  • 作者认为CEA仍是严重颈动脉狭窄治疗的金标准,使用双层微网支架的CAS在部分临床情况下可考虑为有用且安全的替代选择。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Severe carotid stenosis (CS) is a major risk factor for stroke. Carotid Endarterectomy (CEA) is the gold standard revascularization technique of CS while carotid artery stenting (CAS) is considered an alternative treatment option, especially in high-risk patients or those with relative contraindications to CEA. The aim of this study was to evaluate the results of CEA and CAS with Roadsaver® stent device. METHODS: We made a retrospective analysis of 119 patients undergoing treatment of CS. All CS were evaluated with imaging exams. The patients were divided into CEA group and CAS group. As primary endpoints of the study overall and cardiovascular cause - related mortality, freedom from stroke, and restenosis were considered. All patients were followed up and revaluated with duplex scan over a minimum of 6 months and a maximum of 36 months (follow-up mean time 22.3 ± 3.4 months). RESULTS: In the whole cohort 86 of 119 patients underwent CEA and 33 of 119 CAS. Risk factors were superposable in both groups. During follow-up, we observed 4 deaths, 2 cardiovascular events and 12 restenosis. CEA was associated with lower death probability than CAS (P = 0.036). Probability of Restenosis and cardiovascular events did not vary between CAS and CEA groups. CONCLUSIONS: Albeit CEA remains the gold standard for the treatment of severe CS, CAS with new double layer micromesh stent can be considered a useful and safe alternative in some clinical conditions.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Bracale UM, Peluso A, Di Mauro E, et al. Carotid Endarterectomy versus Carotid Artery Stenting With Double-Layer Micromesh Carotid Stent: Contemporary Results of a Single-Center Retrospective Study. Ann Vasc Surg. 2021. PMID: 34902476. doi:10.1016/j.avsg.2021.10.073

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。